Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Should Early-Stage NIH Funding Influence Pharmaceutical Drug Pricing?

Value in Health(2025)10.1016/j.jval.2025.09.3065Source: DataRank Database

Should Early-Stage NIH Funding Influence Pharmaceutical Drug Pricing? is a research paper published in Value in Health (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: closedTopics (24)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

R. Brett McQueen ORCID,William V. Padula

Live enrichment

PubMed:41093069 OpenAlex:https://openalex.org/W4415227424

AbbVie

National Institutes of Health

Micropalaeontological Society

PhRMA Foundation

FWCI

0.00

Citation Percentile

0.4%

closedLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

publisherhttps://api.elsevier.com/content/article/PII:S1098301525056220?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098301525056220?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jval.2025.09.3065

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41093069

Fields of Study

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifeInnovation Policy and R&D

MeSH Terms

Drug DevelopmentDrug IndustryFinancing, GovernmentHumansNational Institutes of Health (U.S.)Research Support as TopicUnited StatesDrug CostsPublic-Private Sector Partnerships

Keywords

IncentiveGeneral partnershipDrug pricingDrugPublic fundingDrug pricesSocial WelfareTechnology TransferBayh-dole ActBiopharmaceutical InnovationPrice Claw-backsReasonable Pricing

Should Early-Stage NIH Funding Influence Pharmaceutical Drug Pricing?

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics